Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Efungumab> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- Efungumab abstract "Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues.Chemically, efungumab is a single-chain variable fragment of a human monoclonal antibody.As such, it potentially act similarly to an IgA - inhibiting by binding and blocking.Its ability to potentiate the effects of the antifungal amphotericin B in culture were later found to be non-specific.".
- Efungumab atcPrefix "none".
- Efungumab fdaUniiCode "BM86P708HW".
- Efungumab wikiPageID "9701506".
- Efungumab wikiPageLength "2859".
- Efungumab wikiPageOutDegree "14".
- Efungumab wikiPageRevisionID "546058527".
- Efungumab wikiPageWikiLink Amphotericin_B.
- Efungumab wikiPageWikiLink Candidiasis.
- Efungumab wikiPageWikiLink Category:Novartis.
- Efungumab wikiPageWikiLink European_Medicines_Agency.
- Efungumab wikiPageWikiLink Fungemia.
- Efungumab wikiPageWikiLink Hsp90.
- Efungumab wikiPageWikiLink Human.
- Efungumab wikiPageWikiLink IgA.
- Efungumab wikiPageWikiLink Immunoglobulin_A.
- Efungumab wikiPageWikiLink Intravenous.
- Efungumab wikiPageWikiLink Intravenous_therapy.
- Efungumab wikiPageWikiLink Monoclonal_antibody.
- Efungumab wikiPageWikiLink Novartis.
- Efungumab wikiPageWikiLink Pharmaceutical_drug.
- Efungumab wikiPageWikiLink Single-chain_variable_fragment.
- Efungumab wikiPageWikiLinkText "Efungumab".
- Efungumab wikiPageWikiLinkText "Mycograb".
- Efungumab wikiPageWikiLinkText "efungumab".
- Efungumab atcPrefix "none".
- Efungumab bioavailability "Not applicable".
- Efungumab chemspiderid "NA".
- Efungumab eliminationHalfLife "-7200.0".
- Efungumab hasPhotoCollection Efungumab.
- Efungumab mabType "scFv".
- Efungumab molecularWeight "Approximately 27.2 kDa".
- Efungumab proteinBound "High".
- Efungumab routesOfAdministration Intravenous_therapy.
- Efungumab source "u".
- Efungumab target "fungal Hsp90".
- Efungumab tradename "Mycograb".
- Efungumab type "mab".
- Efungumab unii "BM86P708HW".
- Efungumab verifiedfields "changed".
- Efungumab verifiedrevid "447746895".
- Efungumab wikiPageUsesTemplate Template:Antiinfective-drug-stub.
- Efungumab wikiPageUsesTemplate Template:Drugbox.
- Efungumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Efungumab wikiPageUsesTemplate Template:Monoclonals_for_infectious_disease_and_toxins.
- Efungumab wikiPageUsesTemplate Template:Reflist.
- Efungumab subject Category:Novartis.
- Efungumab hypernym Drug.
- Efungumab type Article.
- Efungumab type ChemicalSubstance.
- Efungumab type Company.
- Efungumab type Drug.
- Efungumab type Antibody.
- Efungumab type Article.
- Efungumab type Chemical.
- Efungumab type Company.
- Efungumab type Drug.
- Efungumab type ChemicalObject.
- Efungumab type Thing.
- Efungumab type Q8386.
- Efungumab comment "Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive Candida infection in combination with amphotericin B.".
- Efungumab label "Efungumab".
- Efungumab sameAs إفونغوماب.
- Efungumab sameAs Efungumab.
- Efungumab sameAs m.02pplfp.
- Efungumab sameAs Q3720273.
- Efungumab sameAs Q3720273.
- Efungumab wasDerivedFrom Efungumab?oldid=546058527.
- Efungumab isPrimaryTopicOf Efungumab.